C & O Pharmaceutical Technology (Holdings) says net profit increased 18% to HK$30 million ($5.5 million) for the three months ended 31 December 2009 (2QFY10).
Group revenue grew 18% to HK$170 million due to its increased marketing efforts in building its corporate brand name among doctors and patients in China as well as increased sales in Exclusive and C&O Branded products.
